Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Other Working Capital Changes (2016 - 2025)

Dexcom (DXCM) has disclosed Other Working Capital Changes for 16 consecutive years, with $6.9 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes rose 186.25% to $6.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.8 million through Dec 2025, up 155.17% year-over-year, with the annual reading at $14.8 million for FY2025, 155.17% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was $6.9 million at Dexcom, up from $2.4 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $97.9 million in Q1 2022, with the low at -$31.6 million in Q3 2024.
  • Average Other Working Capital Changes over 5 years is $7.7 million, with a median of $550000.0 recorded in 2022.
  • The sharpest move saw Other Working Capital Changes surged 1525.81% in 2022, then crashed 1176.92% in 2023.
  • Over 5 years, Other Working Capital Changes stood at $3.1 million in 2021, then soared by 1525.81% to $50.4 million in 2022, then tumbled by 112.1% to -$6.1 million in 2023, then plummeted by 31.15% to -$8.0 million in 2024, then soared by 186.25% to $6.9 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at $6.9 million, $2.4 million, and $22.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.